Formulation Development & CTM Manufacturing Services

Size: px
Start display at page:

Download "Formulation Development & CTM Manufacturing Services"

Transcription

1 Formulation Development & CTM Manufacturing Services VxP Pharma Purdue Research Park 5225 Exploration Drive Indianapolis, IN Tel: Fax:

2 VxP Pharmaprovides an extensive range of services and technical support for the development and production of sterile and non-sterile products for clinical trial materials. Oral Solid: Oral Liquid: Topical: Tablets, Effervescent Tablets, Capsules, Granulate Solution, Suspension, Emulsion, Liquid-filled capsule Gel, Cream, Ointment, Lotion Transdermal: Single-layer, Double-layer, Reservoir Sterile Liquid: Solution, Suspension, Lyophilized, Emulsion Ophthalmic: Solution, Suspension, Ointment Combination: Multi-layer Tablet, Multi-particulate Drug Delivery Other: Potent, Cytotoxic & Scheduled Compounds (CII-CV)

3 Development Services: Drug Characterization Preformulation Studies Formulation Development Analytical Development Release & Stability Testing Services Overview Manufacturing Services: Clinical Trial Materials GMP and Non-GMP Production Niche Commercial Manufacturing

4 Analytical Services Experienced Professionals in Analytical Chemistry Method development, Qualification and Validation Raw Material Testing (select) Cleaning Analysis/Verification Full Release & Stability Testing Stability Storage ICH Conditions 25 o C/60%RH, 30 o C/65%RH, 40 o C/75%RH Custom conditions also available

5 Formulation Services Solids Tablets, Capsules, Modified Release, Granules, Pellets, Coatings Semi-Solids Creams, Gels, Ointments, Lotions Dispersed Systems Emulsions & Suspensions Liquids/Solutions Oral, Ophthalmic, Parenteral Transdermal

6 Formulation Services We can provide the facilities and expertise to work with your most challenging drug formulation issues: Solubility issues Unstable compounds Innovative delivery options Low dose formulations Controlled drugs (CII CV) High potency compounds Cytotoxic compounds

7 Formulation Services Our scientists have years of experience and the necessary equipment to develop a wide-range of dosage forms: Solubilizing water-insoluble drugs Stabilizing unstable molecules through formulation & excipient selection Taste masking/flavoring Bioavailability enhancement Excipient selection and Compatibility studies Particle size reduction Formulation screening & Feasibility studies

8 Clinical Trial Materials (CTM) Manufacturing We offer technical resources, capacity, flexibility, and the expertise to develop and manufacture virtually any clinical dosage form with strict quality compliance. Processes optimized for future commercial scale-up Pharmaceuticalmanufacturing in support of Phase I-IIIclinical supply needs for solids, liquids, semi-solids, topicals, and transdermals. Including packaging and labeling in: Blister & Strip Packs Bottles, Vials & Syringes Tubes Sachets & Pouches

9 Clinical Trial Materials (CTM) Manufacturing Manufacture of matching placebo for clinical studies. In support of blinded clinical studies, we provide batch manufacturing of matching placebo supplies, as well as supplies for comparator studies. Process qualification and cleaning verification VxP Pharma follows the FDA guidance and incorporates appropriate elements of process validation for the manufacture of human drug products. Full cgmp compliance, accountability and document traceability Compliant with Title 21 CFR Part 11, all data 100% inspected and quality audited to ensure full cgmp manufacturing compliance.

10 Dosage Forms Contract Manufacturing Services API in Capsule/Bottles Tablets Composite, Bi-layer, Tri-layer Coated Capsules Liquid, Solid Coated Over-encapsulation Liquids Solution, Topical, Emulsion, Suspension, Parenteral Transdermals

11 Contract Manufacturing Services Manufacturing Processes Fluid Bed Granulation (Wurster& Top Spray) High/Low Shear Granulation Roller Compaction Direct Compression Tabletting Encapsulation Tablet/Particle Coating (Aqueous& Solvent) Ophthalmic/Otic Solutions/Ointments Contact Us Today for details on Sterile Process Development

12 Contract Manufacturing Services Packaging & Labeling Bulk, Bottles, Sachets, Tubes, Vials, Blisters, Syringes Glass, HDPE, PET, PS, and Protective Coloring Labeling Single Panel, Booklet, Blinded, Randomized, Multi-language Coated Tamper Sealing, Desiccant, Child Resistant Secondary Packaging Cartons Wallets & Dosepacks Complex kits

13 Contract Manufacturing Services Technology Transfer Extensive experiencewith Technology Transfer process from concept to commercialization transfer packages. Our technology transfer experts provide in-depth experience with: Site Transfer Equipment Selection and Validation (IQ, OQ, PQ) Existing Process Optimizations (Lean and Six Sigma) Batch Record Development Validation Protocol Preparation and Execution SOP Development and Method Development Alternate Raw Material Evaluation and Re-formulation Scale-up Assistance from feasibility to commercialization

14 Analytical & Bioanalytical Services VxP Pharmaprovides an extensive range of analytical services and technical support for method development, validation and testing for multiple pharmaceutical and biopharmaceutical applications. API Testing Product Development Testing CMC/Compendial Testing

15 Discover The Benefits Our scientists have expertise in virtually every dosage form giving us the advantage to quickly and effectively create solutions to formulation issues. Ourstaff has over 200+ years of combined experience in contract pharmaceutical development. Ourmanufacturing facilities and development teams are designed to provide you the greatest flexibility while maintaining quality throughout the entire project.

16 THANK YOU For additional information: VxP Pharma Phone:

in full-service contract pharmaceutical development and manufacturing

in full-service contract pharmaceutical development and manufacturing in full-service contract pharmaceutical development and manufacturing THE Norwich Advantage Norwich is a recognized leader in full service contract pharmaceutical development and manufacturing. As a single-source

More information

Next Generation Pharma Solutions

Next Generation Pharma Solutions 02/2008 For product development, clinical trials services, contract manufacturing and cold chain and logistics services partner with NextPharma Next Generation Pharma Solutions www.nextpharma.com Next

More information

At LATITUDE, we only do one thing, and we do it very well.

At LATITUDE, we only do one thing, and we do it very well. Formulation Experts for Insoluble Compounds At LATITUDE, we only do one thing, and we do it very well. LATITUDE Pharmaceuticals Inc. has been tackling the most difficult drug formulation challenges for

More information

NUVISAN GROUP. Our Philosophy

NUVISAN GROUP. Our Philosophy NUVISAN GROUP Our Philosophy 2 EARLY DEVELOPMENT Introduction to Nuvisan Fully integrated Contract Research Organisation headquarted in Neu-Ulm, southern part of Germany. Nuvisan - Early Development Headquartered

More information

FROM CLINICAL TO COMMERCIAL CUSTOM CAN. An overview of our Development and Manufacturing capabilities

FROM CLINICAL TO COMMERCIAL CUSTOM CAN. An overview of our Development and Manufacturing capabilities FROM CLINICAL TO COMMERCIAL CUSTOM CAN An overview of our Development and Manufacturing capabilities THE CUSTOM DIFFERENCE Established in 1979, Custom Pharma Services has grown to become the go-to resource

More information

CGMP Requirements for Investigational Products

CGMP Requirements for Investigational Products PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health

More information

Pharmaceutical Sciences

Pharmaceutical Sciences SRI International Biosciences From Idea to IND Research on Disease Mechanisms Drug Discovery Drug Metabolism, Pharmacokinetics, & Toxicology Services Pharmaceutical Sciences Preclinical Development Planning

More information

Our vision APL

Our vision APL Our vision We want be the most attractive partner and workplace for development and manufacturing of extemporaneous drug formulations and pharmaceuticals. APL 2018 2 Our task Our task is to develop and

More information

HISTORY AND MILESTONES

HISTORY AND MILESTONES HISTORY AND MILESTONES HISTORY AND MILESTONES DOC S.r.l., Documentation Organization & Consultancy, was established in 1997 by MASCO group C.E.O. Eng. Alberto Borella and Eng. Paolo Curtò who became Managing

More information

Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group

Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group Dynamic Future. Reliable Partnership. With a turnover of approximately 1 billion USD, the Aenova Group is one of the leading companies

More information

Single Best Way To Deliver. Blow-Fill-Seal Liquid Stick-Pack Powder Stick-Pack Effervescent Global Drug Development Program

Single Best Way To Deliver. Blow-Fill-Seal Liquid Stick-Pack Powder Stick-Pack Effervescent Global Drug Development Program Single Best Way To Deliver Blow-Fill-Seal Liquid Stick-Pack Powder Stick-Pack Effervescent Global Drug Development Program 15 A Single Best Way To Differentiate Unither offers a range of innovative single

More information

AdaptDose, an innovative platform that reduces product development time and costs by 30% or more

AdaptDose, an innovative platform that reduces product development time and costs by 30% or more WHITE PAPER January 2017 AdaptDose, an innovative platform that reduces product development time and costs by 30% or more Frontida BioPharm, Inc. Ron Connolly 01.01.2017 CONTENTS ABSTRACT INTRODUCTION

More information

GLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION

GLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION GLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION Redefining the standards for accuracy and reliability. About PTI PTI Packaging Technologies & Inspection is headquartered in Tuckahoe,

More information

Contract Manufacturing Services for Pre-filled Syringes

Contract Manufacturing Services for Pre-filled Syringes Contract Manufacturing Services for Pre-filled Syringes From Standard Solutions to Complex Products Stefan Czvitkovich, PhD Director Product Partnering Sterile Pharmaceuticals Central Europe CPhI woldwide

More information

Performance Testing of Novel Dosage Forms

Performance Testing of Novel Dosage Forms RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies

More information

CE 7smart Flow-Through Dissolution System

CE 7smart Flow-Through Dissolution System CE 7smart Flow-Through Dissolution System In-vitro drug release testing in compliance with USP apparatus 4, EP, and JP Configurations for various methods and analytical requirements Specific flow-through

More information

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET National Drug Authority Head Office Rumee Towers Plot 19, Lumumba Avenue P. O. Box 23096 Kampala, Uganda

More information

Headline two lines or three lines. Acino Contract Manufacturing Overview Felix Faupel Global Key Account Manager, Contract Manufacturing

Headline two lines or three lines. Acino Contract Manufacturing Overview Felix Faupel Global Key Account Manager, Contract Manufacturing Headline two lines or three lines Acino Contract Manufacturing Overview Felix Faupel Global Key Account Manager, Contract Manufacturing Contract Manufacturing Technology we re proud of We have the know-how,

More information

Alkermes Contract Pharma Services

Alkermes Contract Pharma Services Alkermes Contract Pharma Services Highly Potent, Poorly Soluble Product Manufacturing Contract, with 100% OTIF #501 April 2013 Fidelma Callanan Senior Director, Marketing and Commercial Development Contents

More information

COUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA

COUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA COUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA WHO WE ARE DPT is a Contract Development and Manufacturing

More information

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D.

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D. Approval Review of Generic Drugs Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D. Outline of Presentation Introduction Approval Review of Generic Drugs Equivalency review Conformity audit Conclusion

More information

Page 1

Page 1 Engineers to Healthcare Industry INTERTECH EQUIPTECHNOLOGIES PVT. LTD. Company Presentation 2014 www.intertechequip.com Page 1 INTERTECH Production facility Total Fabrication Area 75,000 ft2 & Clean room

More information

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Balancing the time, cost and risk of drug development Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Communicating vessels Risk Time Cost Communicating vessels

More information

PLANKSTADT EXPERTS TAKING CARE

PLANKSTADT EXPERTS TAKING CARE CordenPharma PLANKSTADT EXPERTS TAKING CARE Our History 1977 - Start of Packaging activities (ICI Pharma) 1980 - Start of Formulation activities (ICI Pharma) 1995 - First Pre-approval Inspection by FDA

More information

Guidelines for Pharmaceutical Equivalence Requirements

Guidelines for Pharmaceutical Equivalence Requirements Guidelines for Pharmaceutical Equivalence Requirements Version 1.1 1 September 2010 Page 1 of 9 Guidelines for Pharmaceutical Equivalence Requirements Version 1.1 Drug Sector Saudi Food & Drug Authority

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

BCS Organizational Chart

BCS Organizational Chart BE&K Validation BCS Organizational Chart Business Development Mgr. Dwight Rivera President Accountant QA and Compliance Technical Services Engineering / Manufacturing Packaging and Inspection Sr. QA Sr.

More information

GUIDELINE FOR THE STABILITY TESTING

GUIDELINE FOR THE STABILITY TESTING 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)

More information

Oral Dosage Formulation Development

Oral Dosage Formulation Development Oral Dosage Formulation Development Achieving faster formulation of solid oral dosage forms for FIH supplies Dr. Colin Lorimer - published April 29, 2011 The pharmaceutical industry is increasingly looking

More information

Sam Halaby OSD Subject Matter Expert

Sam Halaby OSD Subject Matter Expert OSD Subject Matter Expert Education B.S., Chemical Engineering - Clarkson University B.S., Interdisciplinary Engineering and Management - Clarkson University Professional Associations Parenteral Drug Association

More information

Bringing ideas to life. Full-service pharmaceutical, nutraceutical and cosmetic contract manufacturing

Bringing ideas to life. Full-service pharmaceutical, nutraceutical and cosmetic contract manufacturing Bringing ideas to life Full-service pharmaceutical, nutraceutical and cosmetic contract manufacturing Bringing ideas to life We built our Swiss pharmaceutical company on one idea born over 70 years ago,

More information

CONVENIENCE FOR PATIENTS

CONVENIENCE FOR PATIENTS the dermal experience Co-Development CONVENIENCE FOR PATIENTS The dermal delivery route is well established. Millions of patients globally rely on delivery systems for topical and systemic treatments administered

More information

Extractables and leachables: An Introduction

Extractables and leachables: An Introduction Extractables and leachables: An Introduction Tim Hulme Smithers Rapra THulme@smithers.com 44(0)1939 252 418 1 Extractables and leachables: An Introduction Tim Hulme Smithers Rapra thulme@smithers.com 2

More information

ASCENDIA PHARMACEUTICALS Aspiring for Better Medicine

ASCENDIA PHARMACEUTICALS Aspiring for Better Medicine ASCENDIA PHARMACEUTICALS Aspiring for Better Medicine Ascendia Pharmaceuticals, founded in 2012, is a privately-owned, speciality pharmaceutical company dedicated to developing enhanced formulations of

More information

Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur

Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur GMP ( Adopted in 1975 ) In India Good manufacturing practices are the practices required in order to conform to guidelines recommended

More information

CORPORATE PRESENTATION

CORPORATE PRESENTATION CORPORATE PRESENTATION About us. Established in 1973, Micro Labs is a fully integrated pharmaceutical company, present across the entire pharmaceutical value chain from Research and Development, Active

More information

Formulation Development Services. Your trust is our reward

Formulation Development Services. Your trust is our reward Formulation Development Services. Your trust is our reward Index Who we are? Mission and Vision Where we can help you? Infrastructure and Systems Site Plan Services we offer Technologies we practice Quality

More information

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &

More information

Intertek Melbourn Company Presentation. MIBio 2016

Intertek Melbourn Company Presentation. MIBio 2016 Intertek Melbourn Company Presentation MIBio 2016 November 2016 Global Leader in quality solutions across all industries Innovative and bespoke quality solutions for our clients 24/7 FTSE 100 company in

More information

BEACONS. Exceeding. Expectations. Pharmaceuticals. Quality Pharmaceutical Manufacturing Services

BEACONS. Exceeding. Expectations. Pharmaceuticals. Quality Pharmaceutical Manufacturing Services BEACONS Pharmaceuticals Exceeding Expectations Quality Pharmaceutical Manufacturing Services BEACONS Pharmaceuticals Quality with Trust, Service with Excellence Founded in 1970, with headquarters in, Beacons

More information

Pharmaceutical Packaging

Pharmaceutical Packaging Pharmaceutical Packaging 2017 2021 Section I: Introduction A. Pharmaceuticals defined B. Pharmaceutical packaging defined C. Study organization D. Methodology E. Geographic regions F. Conventions Section

More information

PG Diploma in Pharmaceutical Quality Assurance onwards- CCII Page 1 of 5

PG Diploma in Pharmaceutical Quality Assurance onwards- CCII Page 1 of 5 PG Diploma in Pharmaceutical Quality Assurance 2014-15 onwards- CCII Page 1 of 5 BHARATHIAR UNIVERSITY: COIMBATORE-641 046 CENTRE FPR COLLABORATION OF INDUSTRY AND INSTITUTION(CCII) POST GRATUATE DIPLOMA

More information

How to Avoid Common Deficiencies in INDs and NDAs. Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER

How to Avoid Common Deficiencies in INDs and NDAs. Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER How to Avoid Common Deficiencies in INDs and NDAs Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER 1 Structure of FDA Office of Commissioner Chief Scientist FOODS Medical Products & Tobacco

More information

A Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics

A Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics Chester Medical Solutions

More information

Kollidon The Original Setting new standards in stability, purity and patient safety.

Kollidon The Original Setting new standards in stability, purity and patient safety. Kollidon The Original Setting new standards in stability, purity and patient safety. Now with new PeroXeal packaging Bernhard Fussnegger, an enabler in excipients Pharma Ingredients & Services. Welcome

More information

FOOD AND DRUGS AUTHORITY

FOOD AND DRUGS AUTHORITY G H A N A FOOD AND DRUGS AUTHORITY GUIDELINES FOR STABILITY TESTING OF ACTIVE PHARMACEUTICAL INGREDIENTS AND FINISHED PHARMACEUTICAL PRODUCTS Document No: FDA/DRI/DER/GL-STP/2013/07 Date of First Adoption:

More information

ADVANCES IN PHARMACEUTICAL INDUSTRY FOR WELLNESS AND SUSTAINABLE HEALTH

ADVANCES IN PHARMACEUTICAL INDUSTRY FOR WELLNESS AND SUSTAINABLE HEALTH ADVANCES IN PHARMACEUTICAL INDUSTRY FOR WELLNESS AND SUSTAINABLE HEALTH Faculty of Pharmaceutical Sciences Chulalongkorn University Industrial pharmacy is a discipline which includes manufacturing, development,

More information

A Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics

A Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics A Unique Resource Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics Chester Medical Solutions

More information

Investigational Product (Pharmaceutical) Management. Sudhakar Bangera MD, MMedSc Program Director, CDSA

Investigational Product (Pharmaceutical) Management. Sudhakar Bangera MD, MMedSc Program Director, CDSA Investigational Product (Pharmaceutical) Management Sudhakar Bangera MD, MMedSc Program Director, CDSA Investigational Product Definition (CDSCO GCP) - A pharmaceutical product (including the Comparator

More information

Extractables & Leachables. Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies

Extractables & Leachables. Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies Extractables & Leachables Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies Ph.D. Pfizer Global Research and Development Bethesda 23/02/2011 Thresholds and

More information

Quality is Our Promise.

Quality is Our Promise. Quality is Our Promise. Our goal at KRS Global Biotechnology is to provide the highest quality pharmaceutical preparations. We accomplish this with an unrivaled quality assurance and quality control program

More information

Vetter Development Service

Vetter Development Service A unique blend of expertise for clinical manufacturing Vetter Development Service Supporting your compound s success Answers that work 1 Your molecule s future starts here. By the time your new injectable

More information

BRIEFING 1168 Compounding for Phase I Investigational Studies,

BRIEFING 1168 Compounding for Phase I Investigational Studies, BRIEFING 1168 Compounding for Phase I Investigational Studies, PF 39(5) [Sept. Oct. 2013]. The current proposed chapter in PF 43(3) [May June 2017] is posted online at www.usp.org/usp-nf/notices/compounding-forphase-i-investigational-studies

More information

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form.

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form. The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form. Three major needs that the formulation into a specific dosage form directly address

More information

Partner with the Global Leader in Drug Delivery Systems

Partner with the Global Leader in Drug Delivery Systems 3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Northridge, CA, USA Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into Thousands

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Handling and Retention of BA and BE Testing Samples U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) May 2004

More information

Guidance for Industry

Guidance for Industry Guidance for Industry ANDAs: Blend Uniformity Analysis DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should

More information

2018 EDITORIAL COVERAGE. Connecting the Pharma Industry for 28 Years.

2018 EDITORIAL COVERAGE. Connecting the Pharma Industry for 28 Years. 2018 EDITORIAL COVERAGE Connecting the Pharma Industry for 28 Years EDITORIAL COVERAGE: EXPERT INSIGHT AND ANALYSIS Pharmaceutical Technology Europe sets the standard for publishing independent, industry-leading

More information

Howida Kamal, Ph.D. Ass. Prof. of Pharmaceutics, Cairo University

Howida Kamal, Ph.D. Ass. Prof. of Pharmaceutics, Cairo University Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University Dosage forms Sterile Free from all forms of microbial life (vegetative & sporing) Free from pathogens Non-sterile Extent of total bioburden

More information

Pharmaceutical Packaging

Pharmaceutical Packaging Pharmaceutical Packaging 2017 2021 Section I: Introduction A. Pharmaceuticals defined B. Pharmaceutical packaging defined C. Study organization D. Methodology E. Geographic regions F. Conventions Section

More information

Inspection. Implementation of ICH Q8, Q9, Q10

Inspection. Implementation of ICH Q8, Q9, Q10 Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory

More information

Contract Packaging Capabilities

Contract Packaging Capabilities Contract Packaging Capabilities Table of Contents Contract Packaging Capabilities Corporate Overview Contract Packaging - Overview Contract Packaging - Blister Packaging Contract Packaging - Pouch Packaging

More information

Advancing Development & Manufacturing. On target. On topic EDITORIAL CALENDAR.

Advancing Development & Manufacturing. On target. On topic EDITORIAL CALENDAR. Advancing & On target. On topic. EDITORIAL CALENDAR EDITORIAL COVERAGE: EXPERT INSIGHT AND ANALYSIS Pharmaceutical Technology sets the standard for publishing independent, industry-leading information

More information

Derivation and Justification of Safety Thresholds

Derivation and Justification of Safety Thresholds Derivation and Justification of Safety Thresholds Douglas J. Ball, MS, DABT Chair, PQRI L&E Toxicology Subgroup Research Fellow, Safety Sciences - Pfizer, Inc. Agenda Basic Definitions Current Regulatory

More information

MARIFARM LLC PRODUCTION ABOUT US

MARIFARM LLC PRODUCTION ABOUT US MARIFARM LLC PRODUCTION ABOUT US 2018 KEY INFORMATION COMPANY NAME: HEADQUARTERS: OWNERSHIP: SHARE CAPITAL: SHARE CAPITAL: FOUNDED: Marifarm LLC Maribor, Slovenia (EU) 100% ARTERIUM International BV 4.539.731,46

More information

We make drugs smarter

We make drugs smarter We make drugs smarter Brookwood Pharmaceutical Services WE MAKE DRUGS SMARTER Using our 40 years of experience, our state of the art facilities and our IP protected technologies, we leverage existing capabilities

More information

EXPERIENCE AT YOUR SIDE A CDMO THAT DELIVERS ON ITS COMMITMENTS. EXPERIENCE THE BENEFITS WITH AVARA

EXPERIENCE AT YOUR SIDE A CDMO THAT DELIVERS ON ITS COMMITMENTS.   EXPERIENCE THE BENEFITS WITH AVARA EXPERIENCE AT YOUR SIDE A CDMO THAT DELIVERS ON ITS COMMITMENTS EXPERIENCE THE BENEFITS WITH AVARA www.avara.com A GROWTH STRATEGY Avara was founded and is led by a team of industry veterans who have significant

More information

Complexity of Retention Samples Selection in non-traditional Bioequivalence studies

Complexity of Retention Samples Selection in non-traditional Bioequivalence studies Complexity of Retention Samples Selection in non-traditional Bioequivalence studies Nageshwar R Thudi Ph.D. Director-Clinical R&D Teva Pharmaceuticals Disclaimer The views expressed herein are the views

More information

Development of paediatric formulations - points to consider

Development of paediatric formulations - points to consider Development of paediatric formulations - points to consider Workshop on Paediatric Formulations II London, 8 November 2011 Presented by: Ann Marie Kaukonen Scientific Administrator, Paediatric Medicines,

More information

USP s Perspective on Drug Product Performance Test

USP s Perspective on Drug Product Performance Test USP s Perspective on Drug Product Performance Test Course Overview 1. The concept of in vitro dissolution Definition and application 2. Compendial dissolution/ drug release testing 3. Method development

More information

Developing new drug products is very expensive, especially

Developing new drug products is very expensive, especially As appeared in March 2018 Tablets & Capsules www.tabletscapsules.com formulation Developing fixed-dose combinations Amar Patel, Bruhalkumar Shah, Deep Patel, Satish Shetty, and Anthony Qu Halo Pharmaceuticals

More information

QbD implementation in Generic Industry: Overview and Case-Study

QbD implementation in Generic Industry: Overview and Case-Study QbD implementation in Generic Industry: Overview and Case-Study Inna Ben-Anat, QbD Strategy Leader, Teva Pharmaceuticals IFPAC JAN 2013 R&D Three Core Components of QbD and Generic Industry: How Do They

More information

Evonik Birmingham Laboratories

Evonik Birmingham Laboratories Evonik Birmingham Laboratories An integrated CDMO for advanced parenterals with a portfolio of delivery technologies, formulation development services and GMP manufacturing Evonik Birmingham Laboratories

More information

Formulations for clinical trials in children: possibilities and pitfalls? Robert Ancuceanu, PhD Member of PDCO and FWG

Formulations for clinical trials in children: possibilities and pitfalls? Robert Ancuceanu, PhD Member of PDCO and FWG Formulations for clinical trials in children: possibilities and pitfalls? Robert Ancuceanu, PhD Member of PDCO and FWG Formulation two meanings Process in which different ingredients, including the active

More information

Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010

Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010 Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010 Overview Goal of Manufacturing Central Question: Why is process

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

Key Definitions 6/16/2015

Key Definitions 6/16/2015 Technology Transfer from a CDMO Perspective Joe Cobb, CPIP Director, Pharmaceutical Development Metrics Contract Services, a division of Mayne Pharma US 18-June-2015 Key Definitions CDMO Contract Development/Manufacturing

More information

7th Training School on Microencapsulation Strasbourg. Februar 2015 Textmasterformat in Mastervorlage eingeben

7th Training School on Microencapsulation Strasbourg. Februar 2015 Textmasterformat in Mastervorlage eingeben 7th Training School on Microencapsulation Strasbourg Februar 2015 1 Dr. Anne Ettner, Glatt Pharmaceutical Services 2 Overview 1. Introduction 2. Fluid bed equipment 3. Basics of fluid bed Wurster technology

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1

More information

Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs

Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs 1 Faculty of Pharmacy H-7624 Pécs, Rókus str.2. 2 Faculty of Pharmacy Department of Pharmacetical Biotechnology Department of

More information

Introduction to CMC Regulatory Affairs

Introduction to CMC Regulatory Affairs Introduction to CMC Regulatory Affairs Bharathi Mamidipudi Regulatory Affairs Consultant II Syner-G Pharma Consulting, LLC Northeastern University, Boston November 10, 2016 My Background Experience ~4

More information

International Journal of Generic Drugs

International Journal of Generic Drugs Photostability STABILITY TESTING in New Drug Products evaluating photostability is foremost for new chemical entities only - not in generic drugs, provided the container-closure protection is the same

More information

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148 Request for Proposal Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148 Dated: October 12 th 2015 Page 1 Table of Contents 1. PURPOSE... 3 2. RFP

More information

Brief Introduction of Aburaihan Company Organization Policy Organization Chart Qualified Human Resource Production Department Engineering Department

Brief Introduction of Aburaihan Company Organization Policy Organization Chart Qualified Human Resource Production Department Engineering Department 1 Contents Brief Introduction of Aburaihan Company Organization Policy Organization Chart Qualified Human Resource Production Department Engineering Department Sanitation and Environment Protection Documentation

More information

Design and Dosage Form. Dr. Deny Susanti

Design and Dosage Form. Dr. Deny Susanti Design and Dosage Form Dr. Deny Susanti Example 1 Aspirin tablet is stable but not as a liquid dosage form How to design liquid form? Soluble or dispersible aspirin tablets-to be dissolved in water Note:

More information

FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS

FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS 02-December-2014 San Diego, CA Kim Huynh-Ba Executive Director PHARMALYTIK Kim.huynhba@pharmalytik.com Overview Stability

More information

Ancona Plant Quality and Innovation 100% MANUFAC TURING SOLUTIONS

Ancona Plant Quality and Innovation 100% MANUFAC TURING SOLUTIONS HIGH Ancona Plant Quality and Innovation 100% MANUFAC TURING SOLUTIONS TECHNOLOGY THE PLANT WHERE A.C.R.A.F. S.p.A. performs the manufacturing activities in the plant of Ancona, capital of the region of

More information

Totally Integrated Solutions for Pharmaceutical Industry

Totally Integrated Solutions for Pharmaceutical Industry Totally Integrated Solutions for Pharmaceutical Industry ABOUT AUSTAR As a global leading solution provider for the pharmaceutical industry, AUSTAR provides pharmaceutical enterprises with comprehensive

More information

RapidFACT: Accelerated Formulation Development for Poorly Soluble Drugs and Modified Release Products

RapidFACT: Accelerated Formulation Development for Poorly Soluble Drugs and Modified Release Products RapidFACT: Accelerated Formulation Development for Poorly Soluble Drugs and Modified Release Products Kevin Kane, Scientific Director, BCP 7 th Annual Global Drug Delivery & Formulation Summit 28 th August

More information

Your partner in the pharmaceutical industry

Your partner in the pharmaceutical industry English Micronisation- and milling service Micronised by GfM Your API Particle size (µm) Your partner in the pharmaceutical industry The... always that little bit finer. We are a family business in the

More information

PHARMACEUTICAL MANUFACTURING

PHARMACEUTICAL MANUFACTURING PHARMACEUTICAL MANUFACTURING WHAT IS PHARMACEUTICAL MANUFACTURING IT IS THE PROCESS OF INDUSTRIAL SCALE SYNTHESIS OF PHARMACEUTICAL DRUG BY PHARMACEUTICAL COMPANIES. THE PROCESS CAN BE BROKEN DOWN INTO

More information

The Benefits of Integrating Metal Detection into Your Product Inspection Program for Consumer Safety. Antoine Dodier & Hitesh Hirani

The Benefits of Integrating Metal Detection into Your Product Inspection Program for Consumer Safety. Antoine Dodier & Hitesh Hirani The Benefits of Integrating Metal Detection into Your Product Inspection Program for Consumer Safety Antoine Dodier & Hitesh Hirani Agenda 1 2 Loma Systems Consumer Safety 3 4 5 6 Metal Contamination Prevention

More information

Early Development Best Practices for Stability- Regulatory Perspective

Early Development Best Practices for Stability- Regulatory Perspective Early Development Best Practices for Stability- Regulatory Perspective IQ Workshop, Feb. 4-5, 2014, Washington, D.C. Ramesh Sood, Ph.D. Division Director (Acting) Office of New Drug Quality Assessment

More information

Providing insight into pharmaceutical formulations

Providing insight into pharmaceutical formulations Providing insight into pharmaceutical formulations Dr Steve Ward-Smith Pharmaceutical Industry The average cost of developing a drug is reported to be approx $500 million, but up to 70% of new chemical

More information

INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1

INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1 INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1 LAB INSTRUCTORS: LECT. ANAS T ARIK NAFEA ASSIST. LECT. ZAINAB HASSAN MAHDI Definition of Industrial Pharmacy The conversion of raw materials into certain dosage

More information

Maximizing Roller Compaction Benefits with Proper Excipient Selection

Maximizing Roller Compaction Benefits with Proper Excipient Selection A sponsored whitepaper. Maximizing Roller Compaction Benefits with Proper Excipient Selection By: Bernhard Fussnegger, Global Development and Technical Marketing, PVP/Coatings, Instant & Modified Release,

More information

ADVANTAGES OF MULTIPARTICULATES (PELLETS):

ADVANTAGES OF MULTIPARTICULATES (PELLETS): INTRODUCTION: Multiparticulate Drug Delivery Systems (MDDS): The concept of multiple unit dosage form was initially introduced in the early 1950 s.these forms play a major role in the design of solid dosage

More information

WHOPAR. SCIENTIFIC DISCUSSION

WHOPAR. SCIENTIFIC DISCUSSION This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1

More information

Pharmaceutical Regulatory Authority GUIDELINE ON APPLICATION FOR REGISTRATION OF UNREGISTERED VETERINARY MEDICINES ALREADY ON THE ZAMBIAN MARKET

Pharmaceutical Regulatory Authority GUIDELINE ON APPLICATION FOR REGISTRATION OF UNREGISTERED VETERINARY MEDICINES ALREADY ON THE ZAMBIAN MARKET GUIDELINE ON APPLICATION FOR REGISTRATION OF UNREGISTERED VETERINARY MEDICINES ALREADY ON THE ZAMBIAN MARKET ABBREVIATIONS µg Microgram API Active Pharmaceutical Ingredient ATC Anatomic Therapeutic Chemical

More information